Cargando…

Small molecule activators of the p53 response

Drugging the p53 pathway has been a goal for both academics and pharmaceutical companies since the designation of p53 as the ‘guardian of the genome’. Through growing understanding of p53 biology, we can see multiple routes for activation of both wild-type p53 function and restoration of mutant p53....

Descripción completa

Detalles Bibliográficos
Autores principales: Ladds, Marcus J G W, Laín, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478124/
https://www.ncbi.nlm.nih.gov/pubmed/30689917
http://dx.doi.org/10.1093/jmcb/mjz006